Knockdown of ANRIL elevates the level of miRNA-122-5p and suppresses cell proliferation, metastasis and invasion in hepatocellular carcinoma (HCC) [58]. This evidence concerns the gene CDKN2B-AS1 and hepatocellular carcinoma.